Image
25.02.2022
Shift-Diabetes: developing dietary support for shift-workers living wi...
The Shift-Diabetes research team at King’s College London is working to understand more about how night w...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more